SCHEMBL19983308

SCHEMBL19983308

CC(=O)Nc1cccc(C(=O)N[C@@H](CCCCNC(=O)OC(C)(C)C)C(=O)CCl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.56
CA2 P00918 4/20 0.56
TDP1 Q9NUW8 8/20 0.50
MAPT P10636 8/20 0.50
NPSR1 Q6W5P4 7/20 0.50
KDM4E B2RXH2 5/20 0.50
SIRT5 Q9NXA8 1/20 0.46
KMT2A Q03164 4/20 0.44
HDAC4 P56524 2/20 0.43
HDAC1 Q13547 2/20 0.43
ATM Q13315 1/20 0.43
PAX8 Q06710 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
MEN1 O00255 3/20 0.42
POLB P06746 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19983279 0.90 CA1 (0.56) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983311 0.87 CA1 (0.51) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983024 0.86 CA1 (0.45) CA1CA2TDP1MAPTNPSR1
SCHEMBL25658901 0.83 HPGD (0.45) MAPTHDAC4HDAC1GAAHDAC3
SCHEMBL19983028 0.81 ALB (0.43) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983070 0.81 SUCNR1 (0.43) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983222 0.81 CA1 (0.42) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983283 0.81 SUCNR1 (0.43) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983272 0.81 TDP1 (0.55) CA1CA2TDP1MAPTNPSR1
SCHEMBL19983221 0.80 CYP3A4 (0.50) TDP1MAPTNPSR1KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2023-05-11 US disclosed
US-11325884-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2022-05-10 US disclosed
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2021-02-25 US disclosed
US-10730826-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2020-08-04 US disclosed
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2019-07-11 US disclosed
WO-2018053353-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP CA1 262/4885CA2 893/4885TDP1 1585/4885
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP CA1 262/4885CA2 893/4885TDP1 1585/4885
US-10730826-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP CA1 262/4885CA2 893/4885TDP1 1585/4885
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP CA1 262/4885CA2 893/4885TDP1 1585/4885
US-11325884-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP CA1 262/4885CA2 893/4885TDP1 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.